Skip to main content
NCBI home page
Journal of Virology logoLink to Journal of Virology
. 1983 Feb;45(2):489–495. doi: 10.1128/jvi.45.2.489-495.1983

Accumulation and breakdown of RNA-deficient intracellular virus particles in interferon-treated NIH 3T3 cells chronically producing Moloney murine leukemia virus.

M Aboud, Y Hassan
PMCID: PMC256441  PMID: 6187933

Abstract

Interferon treatment of NIH 3T3 cells chronically infected with Moloney murine leukemia virus inhibited about 95% of virus release. This inhibition was accompanied by a three- to twofold accumulation of intracellular virions. However, this accumulation could be demonstrated only be exogenous reverse transcriptase reaction assay or radioactive labeling of the assembled viral proteins. It could not be shown by the endogenous reverse transcriptase reaction assay, which depended on endogenous viral RNA, or by labeling the encapsidated viral RNA. It was therefore evident that most of the intracellular virions accumulated in interferon-treated cells were RNA deficient. Hybridization analysis revealed that these virions were deficient of genomic viral RNA, whereas size analysis by gel electrophoresis suggested that the deficiency of 4S RNA normally packaged in Moloney murine leukemia virus was even stronger. Our data also suggested that this RNA deficiency was not due to degradation of the encapsidated RNA, but more likely to a defect in virus assembly. RNA-lacking intracellular virions were unstable; they were found to collapse before being released.

Full text

PDF
489

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aboud M., Kimchi R., Bakhanashvili M., Salzberg S. Intracellular production of virus particles and viral components in NIH/3T3 cells chronically infected with Moloney murine leukemia virus: effect of interferon. J Virol. 1981 Dec;40(3):830–838. doi: 10.1128/jvi.40.3.830-838.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aboud M., Moldovan-Levin D., Salzberg S. Cytoplasmic viral DNA synthesis in exogenous infection of murine leukemia virus: effect of interferon and cycloheximide. J Virol. 1981 Feb;37(2):836–839. doi: 10.1128/jvi.37.2.836-839.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aboud M., Shoor R., Bari S., Hasan Y., Shurtz R., Malik Z., Salzberg S. Biochemical analysis and electron microscopic study on intracellular virions in NIH/3T3 mouse cells chronically infected with Moloney murine leukaemia virus: effect of interferon. J Gen Virol. 1982 Oct;62(Pt 2):219–225. doi: 10.1099/0022-1317-62-2-219. [DOI] [PubMed] [Google Scholar]
  4. Aboud M., Shoor R., Salzberg S. An effect of interferon on the uncoating of murine leukaemia virus not related to the antiviral state. J Gen Virol. 1980 Dec;51(Pt 2):425–429. doi: 10.1099/0022-1317-51-2-425. [DOI] [PubMed] [Google Scholar]
  5. Aboud M., Shoor R., Salzberg S. Effect of interferon on exogenous murine leukemia virus infection. Virology. 1978 Jan;84(1):134–141. doi: 10.1016/0042-6822(78)90225-8. [DOI] [PubMed] [Google Scholar]
  6. Aboud M., Weiss O., Salzberg S. Rapid quantitation of interferon with chronically oncornavirus-producing cells. Infect Immun. 1976 Jun;13(6):1626–1632. doi: 10.1128/iai.13.6.1626-1632.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Aboud M., Wolfson M., Hassan Y., Huleihel M. Rapid purification of extracellular and intracellular Moloney murine leukemia virus. Arch Virol. 1982;71(3):185–195. doi: 10.1007/BF01314870. [DOI] [PubMed] [Google Scholar]
  8. Avery R. J., Norton J. D., Jones J. S., Burke D. C., Morris A. G. Interferon inhibits transformation by murine sarcoma viruses before integration of provirus. Nature. 1980 Nov 6;288(5786):93–95. doi: 10.1038/288093a0. [DOI] [PubMed] [Google Scholar]
  9. Bandyopadhyay A. K., Chang E. H., Levy C. C., Friedman R. M. Structural abnormalities in murine leukemia viruses produced by interferon-treated cells. Biochem Biophys Res Commun. 1979 Apr 27;87(4):983–988. doi: 10.1016/s0006-291x(79)80003-0. [DOI] [PubMed] [Google Scholar]
  10. Billiau A., Edy V. G., Sobis H., de Somer P. Influence of interferon on virus-particle synthesis in oncornavirus-carrier lines. II. Evidence for a direct effect on particle release. Int J Cancer. 1974 Sep 15;14(3):335–340. doi: 10.1002/ijc.2910140306. [DOI] [PubMed] [Google Scholar]
  11. Billiau A. Effect of interferon on RNA tumor viruses. Tex Rep Biol Med. 1977;35:406–419. [PubMed] [Google Scholar]
  12. Billiau A., Heremans H., Allen P. T., De Maeyer-Guignard J., De Somer P. Trapping of oncornavirus particles at the surface of interferon-treated cells. Virology. 1976 Sep;73(2):537–542. doi: 10.1016/0042-6822(76)90416-5. [DOI] [PubMed] [Google Scholar]
  13. Billiau A., Heremans H., Allen P. T., De Somer P. Influence of interferon on the synthesis of virus particles in oncornavirus carrier cell lines. IV. Relevance to the potential application of interferon in natural infectious diseases. J Infect Dis. 1976 Jun;133 (Suppl):A51–A55. doi: 10.1093/infdis/133.supplement_2.a51. [DOI] [PubMed] [Google Scholar]
  14. Bishop J. M. Retroviruses. Annu Rev Biochem. 1978;47:35–88. doi: 10.1146/annurev.bi.47.070178.000343. [DOI] [PubMed] [Google Scholar]
  15. Chang E. H., Friedman R. M. A large glycoprotein of Moloney leukemia virus derived from interferon-treated cells. Biochem Biophys Res Commun. 1977 Jul 11;77(1):392–398. doi: 10.1016/s0006-291x(77)80210-6. [DOI] [PubMed] [Google Scholar]
  16. Chang E. H., Mims S. J., Triche T. J., Friedman R. M. Interferon inhibits mouse leukaemia virus release: an electron microscope study. J Gen Virol. 1977 Feb;34(2):363–367. doi: 10.1099/0022-1317-34-2-363. [DOI] [PubMed] [Google Scholar]
  17. Chang E. H., Myers M. W., Wong P. K., Friedman R. M. The inhibitory effect of interferon on a temperature-sensitive mutant of Moloney murine leukemia virus. Virology. 1977 Apr;77(2):625–636. doi: 10.1016/0042-6822(77)90487-1. [DOI] [PubMed] [Google Scholar]
  18. DALTON A. J., HAGUENAU F., MOLONEY J. B. FURTHER ELECTRON MICROSCOPIC STUDIES ON THE MORPHOLOGY OF THE MOLONEY AGENT. J Natl Cancer Inst. 1964 Aug;33:255–275. [PubMed] [Google Scholar]
  19. Dalton A. J. An electron microscopic study of a virus-induced murine sarcoma (Moloney). Natl Cancer Inst Monogr. 1966 Sep;22:143–168. [PubMed] [Google Scholar]
  20. De Harven E., Friend C. Origin of the viremia in murine leukemia. Natl Cancer Inst Monogr. 1966 Sep;22:79–105. [PubMed] [Google Scholar]
  21. Fan H. Expression of RNA tumor viruses at translation and transcription lebels. Curr Top Microbiol Immunol. 1978;79:1–41. doi: 10.1007/978-3-642-66853-1_1. [DOI] [PubMed] [Google Scholar]
  22. Friedman R. M. Antiviral activity of interferons. Bacteriol Rev. 1977 Sep;41(3):543–567. doi: 10.1128/br.41.3.543-567.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Gerwin B. I., Levin J. G. Interactions of murine leukemia virus core components: characterization of reverse transcriptase packaged in the absence of 70S genomic RNA. J Virol. 1977 Nov;24(2):478–488. doi: 10.1128/jvi.24.2.478-488.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Ikawa Y., Furusawa M., Sugano H. Erythrocyte membrane-specific antigens in Friend virus-induced leukemia cells. Bibl Haematol. 1973;39:955–967. doi: 10.1159/000427928. [DOI] [PubMed] [Google Scholar]
  25. Jamjoom G. A., Naso R. B., Arlinghaus R. B. Selective decrease in the rate of cleavage of an intracellular precursor to Rauscher leukemia virus p30 by treatment of infected cells with actinomycin D. J Virol. 1976 Sep;19(3):1054–1072. doi: 10.1128/jvi.19.3.1054-1072.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Levin J. G., Grimley P. M., Ramseur J. M., Berezesky I. K. Deficiency of 60 to 70S RNA in murine leukemia virus particles assembled in cells treated with actinomycin D. J Virol. 1974 Jul;14(1):152–161. doi: 10.1128/jvi.14.1.152-161.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Levin J. G., Seidman J. G. Effect of polymerase mutations on packaging of primer tRNAPro during murine leukemia virus assembly. J Virol. 1981 Apr;38(1):403–408. doi: 10.1128/jvi.38.1.403-408.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Levin J. G., Seidman J. G. Selective packaging of host tRNA's by murine leukemia virus particles does not require genomic RNA. J Virol. 1979 Jan;29(1):328–335. doi: 10.1128/jvi.29.1.328-335.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Luftig R. B., Conscience J. F., Skoultchi A., McMillan P., Revel M., Ruddle F. H. Effect of interferon on dimethyl sulfoxide-stimulated Friend erythroleukemic cells: ultrastructural and biochemical study. J Virol. 1977 Sep;23(3):799–810. doi: 10.1128/jvi.23.3.799-810.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Maheshwari R. K., Banerjee D. K., Waechter C. J., Olden K., Friedman R. M. Interferon treatment inhibits glycosylation of a viral protein. Nature. 1980 Oct 2;287(5781):454–456. doi: 10.1038/287454a0. [DOI] [PubMed] [Google Scholar]
  31. Montelaro R. C., Bolognesi D. P. Structure and morphogenesis of type-C retroviruses. Adv Cancer Res. 1978;28:63–89. doi: 10.1016/s0065-230x(08)60646-6. [DOI] [PubMed] [Google Scholar]
  32. Morris A. G., Burke D. C. An interferon-sensitive early step in the establishment of infection of murine cells by murine sarcoma/leukaemia virus. J Gen Virol. 1979 Apr;43(1):173–181. doi: 10.1099/0022-1317-43-1-173. [DOI] [PubMed] [Google Scholar]
  33. Pitha P. M., Fernie B., Maldarelli F., Hattman T., Wivel N. A. Effect of interferon on mouse leukaemia virus (MuLV). V. Abnormal proteins in virions of Rauscher MuLV produced in the presence of interferon. J Gen Virol. 1980 Jan;46(1):97–110. doi: 10.1099/0022-1317-46-1-97. [DOI] [PubMed] [Google Scholar]
  34. Pitha P. M., Fernie B., Maldarelli F., Wivel N. A. The errors in assembly of MuLV in interferon treated cells. J Supramol Struct. 1979;12(1):35–46. doi: 10.1002/jss.400120105. [DOI] [PubMed] [Google Scholar]
  35. Salzberg S., Bakhanashvili M., Bari S., Berman I., Aboud M. Characterization of intracellular viral RNA in interferon-treated cells chronically infected with murine leukemia virus. J Virol. 1980 Sep;35(3):694–703. doi: 10.1128/jvi.35.3.694-703.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Sato T., Friend C., De Harven E. Ultrastructural changes in Friend erythroleukemia cells treated with dimethyl sulfoxide. Cancer Res. 1971 Oct;31(10):1402–1417. [PubMed] [Google Scholar]
  37. Sato T., Friend C., Stackpole C., De Harven E. Coating of Friend leukemia virus after treatment with specific antiserum. Cancer Res. 1972 Dec;32(12):2670–2678. [PubMed] [Google Scholar]
  38. Sugano H., Furusawa M., Kawaguchi T., Ikawa Y. Enhancement of erythrocytic maturation of Friend virus-induced leukemia cells in vivo. Bibl Haematol. 1973;39:943–954. doi: 10.1159/000427927. [DOI] [PubMed] [Google Scholar]
  39. Yagi M. J., King N. W., Jr, Bekesi J. G. Alterations of a mouse mammary tumor virus glycoprotein with interferon treatment. J Virol. 1980 Apr;34(1):225–233. doi: 10.1128/jvi.34.1.225-233.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES